Association of Cancer Executives
|
|
- Myra Ramsey
- 5 years ago
- Views:
Transcription
1 Association of Cancer Executives 340B Drug Pricing Program How to Get It and Make the Most of It January 31, 2014
2 ECG Management Consultants, Inc. Our mission is to provide exceptional management consulting services to our healthcare clients. ECG is a national consulting firm focused on offering realistic, implementable solutions to healthcare providers. We are particularly known for our expertise in strategic and business planning, hospital/ physician integration, payor relationships, academic medicine, and service line development. We are a privately held organization that was founded in Our approximately 135 consultants work out of seven offices around the country. ECG s Oncology Practice We have significant experience working with oncology programs, having completed over 220 cancer-related assignments for 120 organizations since Our team includes nationally recognized experts in oncology who hold leadership roles in such organizations as the Association of Community Cancer Centers (ACCC) and the Association of Cancer Executives. We wrote the book on oncology service line planning: Oncology: Strategies for Superior Service Line Performance, published by HealthLeaders Media in December Boston Dallas San Diego San Francisco Seattle St. Louis Washington, D.C. 1
3 Agenda The 340B Drug Pricing Program ( 340B ) is an invaluable program for safety net hospitals. The purpose of this session is to learn how to utilize the 340B program to further a cancer center s clinical and programmatic objectives, as well as to explore partnership models for 340B participation. I. 340B Primer II. Financial Considerations III. Participation Through Partnership IV. Future of 340B and Potential Pitfalls 2
4 I. 340B Primer Overview and History 340B was established by Section 340B of U.S. Public Law , the Veterans Health Care Act of Its purpose is to limit the cost of covered drugs to certain federal and qualified entities. The program requires drug manufacturers to sell outpatient drugs to eligible covered entities (healthcare centers, clinics, hospitals) at significantly reduced prices determined using a statutory formula. Further, 340B is intended to enable covered entities to stretch scarce Federal resources as far as possible, reaching more eligible patients and providing more comprehensive services. The Health Resources and Services Administration (HRSA) 340B Drug Pricing Program & Pharmacy Affairs administers the program. Over 12,000 healthcare facilities have been certified 340B-eligible by the U.S. Department of Health & Human Services (HHS). In January 2010, 340B eligibility was also expanded to include children s hospitals, critical access hospitals (CAHs), freestanding cancer hospitals, rural referral centers (RRCs), and sole community hospital (SCHs). Source: 3
5 I. 340B Primer Eligibility Criteria DSH In the oncology community, most hospitals qualify for 340B based on their DSH status. Requisite DSH percentages vary by type of hospital. Medicare DSH Adjustment Provision The DSH provision was enacted by Section 9105 of COBRA of 1985 and became effective for discharges occurring on or after May 1, The purpose is to identify hospitals that give treatment to a high number of uninsured, underinsured, and Medicaid patients. While the general rule for hospitals is a DSH percentage of at least 11.75%, CAH, RRC, and SCH organizations must have a DSH in excess of 8%. DSH Calculation It is based on overall facility payor mix. The DSH patient percentage is calculated by the following: (Medicare SSI days/total Medicare days) + (Medicaid, non-medicare days/total patient days) 4
6 I. 340B Primer Eligible Drugs and Patients Patients must meet prescribed criteria in order to be eligible to receive 340B medications. Eligible patients are defined as patients who meet all of the following guidelines: Established Relationship The covered entity has established a relationship with the individual, such that the entity maintains records of the individual's healthcare. Responsible for Care The prescription is for a condition for which the individual is currently receiving healthcare services from a healthcare professional. This professional either is employed by the covered entity or provides healthcare under contractual or other arrangements (e.g., referral for consultation), such that responsibility for the care provided remains with the covered entity. More Than a Referral An individual will not be considered a patient of the entity for purposes of 340B if the only healthcare service received by the individual from the covered entity is the dispensing of a drug(s) for subsequent selfadministration or administration in the home setting. It is illegal to sell or provide 340B-priced drugs to persons who are not patients of a covered entity. Currently, vaccines and inpatient drugs are not covered under 340B. 5
7 I. 340B Primer Registration Once it has been determined that the organization is eligible to participate in 340B, it must be formally enrolled, and there are limited 340B registration windows. In order to participate in 340B, eligible organizations/covered entities must register, be enrolled, and strictly comply with all requirements. Covered entities are assigned a 340B identification number that vendors verify before allowing an organization to purchase 340B discounted drugs. New registrations are only accepted during the following time periods, which then determine the effective date for participation in 340B: Registration Date Source: Effective Date January 1 January 15 April 1 April 1 April 15 July 1 July 1 July 15 October 1 October 1 October 15 January 1 For many organizations, meeting the requirements associated with conversion to a hospital outpatient department will determine the implementation timeline. 6
8 I. 340B Primer Potential for 340B Timeline Typically, it takes about 6 to 18 months to begin administering 340B drugs in a new site (generally about 6 months following the end of the cost-report fiscal year). 340B Implementation Process Complete formation of a provider based clinic (provider credentialing, facility renovations, etc.). Submit the provider-based billing (PBB) attestation and 855A form to Medicare, in order to add the new clinic location and begin billing as a provider-based clinic. At the end of the current fiscal year, submit a cost report to CMS, including expenses for the new clinic site. Following submission of the cost report, the hospital may submit an application to HRSA to add a new clinic site during the next quarterly window. After the application is approved, the hospital could begin utilizing 340B medications in the clinic. 7
9 I. 340B Primer Legal Considerations Before enrolling in 340B, it is important to consider all applicable rules and regulations. Stark Law Chemotherapy is considered a designated health service; this designation limits physicians ability to invest in chemotherapy businesses. HOPPS The infusion clinic will be subject to HOPPS (PBB) rules rather than MPFS rules. Presence: Physician presence requirements must be followed. Licensing: Hospital licensing requirements (State Health, The Joint Commission) must be followed. Operation: The clinic must be operated by the hospital. Location: The clinic must be within 35 miles of the hospital s main campus, but does not need to be on the campus. However, requirements vary for offcampus clinics (greater than 250 yards from the primary address of hospital). Billing: Services must be billed by the hospital, and the hospital must buy/provide the drugs. 8
10 I. 340B Primer Provider-Based Definition To further clarify, provider-based and freestanding clinic are Medicare designations that determine Medicare payments to outpatient clinics. Medicare uses the terms provider-based and freestanding to denote who owns and operates ambulatory clinics and how they are billed. Freestanding Clinics Physicians Physicians own and operate the clinic and bill Medicare globally. Provider-Based Clinics Hospital The hospital owns and operates the clinic and bills Medicare. Physicians Physicians practice in the clinic and bill Medicare. Freestanding (also known as physician-based, office-based, non-facility, or Place of Service [POS] 11) refers to a clinic that is owned and operated by physicians and bills Medicare globally. Provider-based (also known as hospital-based, facility, or POS 22) refers to a clinic that is owned and operated by the hospital, and both the hospital and physicians bill Medicare. In order to participate in 340B, an entity must be enrolled as a provider-based clinic. 9
11 I. 340B Primer Provider-Based Status/CMS Requirements Clinical Integration Clinical services of the facility and main hospital are integrated. Professional staff at the facility have clinical privileges at the hospital. The hospital maintains the same monitoring and oversight of the facility as it does for any other department. Medical records for patients treated in the facility are integrated with those of the main hospital. The clinics meet applicable facility requirements under state law. Financial Integration The financial operations of the facility are fully integrated within the hospital s financial system. Income and expenses are shared. Costs arising from the facility are reported in the appropriate cost center of the hospital. Financial status of the facility should be incorporated and readily identified in the hospital s trial balance. Public Awareness The provider-based entity is presented to the public and other payors as part of the main hospital. Patients must be aware that they are entering the provider s facility and will be billed accordingly. This provision will likely require changes to clinic signage and branding. Notification to other payors is also required. These regulations greatly influence the design of potential physician partnership models. 10
12 II. Financial Considerations Drug Pricing Comparison Example On average, 340B participating entities should expect to save at least 29% on drug expenses compared to non-340b average wholesale price (AWP), which is an average of list prices charged by wholesalers to pharmacies. Calculation of Average 340B Brand-Name Drug Savings Non-340B 340B Variance Variance as Percentage of Non-340B AMP 1 $100 $100 $0 0% Adjustment 20% -15.1% AWP $120 $84.90 $ % National Average Markup 2 340B Ceiling Price 1 1 Compared to a drug's average manufacturer price (AMP), covered entities receive a minimum discount of 15.1% for brand-name drugs and 11% for generic and OTC drugs, and they are entitled to an additional discount if the price of the drug has increased faster than the rate of inflation ( 2 The Congressional Budget Office estimates AMP to be approximately 20% less than AWP ( Actual savings vary based on negotiated rates pre- and post-340b, but they typically range from 20% to 40%. 11
13 II. Financial Considerations Potential Programmatic Impact The benefits of 340B can be especially profound for oncology clinics due to the typically high cost and high volume of chemotherapy medications. The impact of providing chemotherapy for one physician s patients is significant. 340B typically yields 20% to 40% savings in drug costs. Medical oncologists typically generate $2.5 million to $3.5 million in drug expenses annually. The reduction in costs, per physician, typically ranges from $500,000 to $1 million per year. With the exception of Medicaid, third-party reimbursement is unaffected by the cost of the drugs; therefore, the cost savings translate directly into enhanced margins. However, some savings may be offset by higher costs incurred in the hospital versus freestanding clinics. 12
14 II. Financial Considerations Benefits to Providers and Service Line A common barrier to 340B implementation is the limited means for sharing drug cost savings with providers. Savings from participation in 340B cannot be passed directly to physicians, as chemotherapy is a designated health service. Therefore, it is common for 340B savings to be used for the following: Improving access to oncology services. Enhancing the oncology service offering (e.g., support services). Funding increases in physician compensation to market-competitive levels.» Any provider compensation arrangement must comply with fair market value (FMV) principles.» The ability to demonstrate financial benefit for the practice will be inversely correlated with current levels of compensation. When 340B savings are used to enhance the overall oncology service line, patients and the broader community are significant beneficiaries. 13
15 II. Financial Considerations Complete Financial Analysis There are numerous financial variables that may change as a result of conversion to PBB status in order to take advantage of 340B. Those highlighted below typically have the most significant variance. Revenue Enhancement Provider-based billing. Hospital managed care contract rates. Change in commercial rates. Cost Savings Drug pricing (340B or hospital GPO). Practice management efficiencies. Other overhead costs (benefits, medical malpractice, etc.). Other Considerations Downstream benefits. Practice growth. Changes in physician production. Changes in physician compensation. Changes in staff compensation. Changes in health plan participation. In addition, the organization must consider one-time expenses, such as facility renovation; IT acquisition; and consulting, legal, and tax advisors. 14
16 III. Participation Through Partnership Alignment Models For organizations that do not qualify for participation in 340B, a variety of partnership models, including both hospital/physician and hospital/hospital alignment, enable access to 340B through an eligible entity. Hospital/Physician Alignment Professional Services Agreement (PSA) Employment Hospital/Hospital Alignment Multi-Hospital Health System Joint Operating Agreement (JOA) In evaluating potential alignment models, it is important for both parties to consider their desired financial, operational, and strategic outcomes. 15
17 III. Participation Through Partnership Hospital/Physician PSA The PSA model preserves much of the physician group s independence while offering a robust alignment structure. Physician Group Hospital Board 2 3 Oncology Service Line Clinical Services PSA 1 Compensation Physician Group 4 JOC Key Features 1. The physician group provides clinical oncology services through a PSA in exchange for a fee. 2. The hospital supports administration activities such as billing, staffing, and IT support. (A variation to this model would include a Management Services Agreement [MSA] with the physician group in addition to the PSA.) 3. The physician group maintains control over clinical coordination, internal compensation distribution, and physician hiring/termination. 4. The JOC would include hospital and medical group representatives (typically 50/50) and would have oversight for the clinic and the contractual relationship between the hospital and physicians. 16
18 III. Participation Through Partnership PSA Key Components Under the PSA model, the physicians would remain independent practitioners and provide services at the hospital. Component Characteristics/Considerations Structure The physicians would continue to be employees of the physician group. Staff could be employed by the hospital or leased to the hospital through an MSA. The clinic must operate as a hospital outpatient clinic (PBB). Funds Flow The hospital bills and collects for all professional and technical services. The hospital funds group compensation and other expenses at the aggregate practice level at a predetermined FMV rate, such as dollars per WRVU. The rate paid to the group would likely also include quality-based incentives and compensation for administrative duties within the practice and the hospital service line. Regulatory When operating as a provider-based clinic, there are additional regulatory requirements that need to be met (e.g., staffing, signage, billing). Any financial incentives must comply with federal and local regulations by not inadvertently creating incentives to reduce patient care or correlating payments to hospital referrals. Management/ Governance The physician group ownership and infrastructure would remain independent and under the control of the physicians. A committee of hospital and physician group members would make key programmatic decisions (e.g., strategic planning, physician recruitment) and administer the PSA. 17
19 III. Participation Through Partnership Hospital/Physician Employment The employment model provides the highest degree of clinical and financial alignment. Payors Hospital Clinical Services 2 Hospital Medical Group 1 Employment Agreement 4 Compensation 3 Physician Key Features 1. A physician is recruited to a medical group or solo practice established by the hospital. 2. The hospital employs the physician full time and handles all administrative functions. Specifically, the hospital performs billing and contracts with payors. 3. The physician is responsible for clinical care. 4. The physician can be employed under a variety of compensation methods: Revenue less expense model. Productivity-based method. Base salary method. Hybrid method. 18
20 III. Participation Through Partnership Employment Key Components Employment offers a more integrated alignment structure than the PSA; however, it will also require more structural changes for all parties. Component Characteristics/Considerations Structure Physicians (and potentially midlevel providers) become hospital employees. Depending on the employment structure, the physician group assets might be purchased by the hospital at FMV levels. Funds Flow The oncologists would be compensated pursuant to individual employment agreements with the hospital, the terms of which would be negotiated. If the hospital has other employed physicians, the compensation structures should be compatible (e.g., include productivity-based and performance incentives). Regulatory If the physicians wish to practice at other community partners, those contracts would need to be carefully structured to ensure that the oncologists could continue to provide regional coverage at these sites and patient access would remain unchanged. Management/ Governance When operating as a provider-based clinic, there are additional regulatory requirements that need to be met (e.g., staffing, signage, billing). The oncology program would be governed through the mechanisms that the hospital already has in place with other employed physicians. 19
21 III. Participation Through Partnership Hospital/Hospital Health System In a multi-hospital health system, the hospital that participates in 340B may operate oncology or infusion clinics across the system. Health System 1 Hospital A Hospital B 3 Oncology Clinic A Oncology Clinic B Key Features 1. Hospital A must be located within 35 miles of Hospital B, per PBB off-campus location regulations. 2. While Hospital A s oncology clinic may remain on the Hospital A campus, it would be enrolled as an outpatient department of Hospital B. 3. Hospital B qualifies for participation in 340B. 4. Clinics A and B would qualify for the reduced drug pricing of 340B. 20
22 III. Participation Through Partnership Health System Key Components For multiple hospitals to align, the simplest option is limited to those that are under a single parent health system and are located within 35 miles of each other. Component Structure Funds Flow Regulatory Management/ Governance Characteristics/Considerations One 340B-eligible entity would enroll all oncology clinics across the system. Due to provider-based clinic regulations for an off-campus site, the operator/provider must be the 340B-qualified hospital. The clinic would be owned/operated by the 340B entity. The health system could use a variety of strategies to credit or transfer funds to the non-340b hospital. Depending on the clinic s configuration and location, there may be a number of steps involved with transferring it from one hospital license to another. Otherwise, there are no new regulatory requirements. A JOC could be established to govern the services covered at all oncology clinics. 21
23 III. Participation Through Partnership Hospital/Hospital JOA The oncology JOA enables two non-system-affiliated hospitals to develop a joint oncology program that leverages 340B at multiple sites of service. Hospital A 1 4 Hospital B Oncology Clinic (Department of B) JOA Oncology Clinic 2 Payors 3 Key Features 1. The funds flow is decided based on the contributions of each hospital (value of the service line and/or capital). 2. Hospital B assumes operation of Hospital A s oncology clinic. The clinic is transferred to Hospital B s license. 3. Hospital B will contract with payors and bill for services provided at both sites. 4. Future net income/loss is reallocated based on each hospital s share in the JOA. 22
24 III. Participation Through Partnership JOA Key Components Component Characteristics/Considerations Structure The model requires transferring the operations of the non-340b hospital's clinic to the partner organization. This model can be structured contractually, without the formation of a NEWCO, reducing legal complexity. It could be transitioned from a contractual relationship to a NEWCO joint venture at any time. Funds Flow Profit is distributed based on the JOA. Financial incentives are aligned: as services grow at either campus, the equity split remains unchanged. However, if additional capital contributions are necessary, the arrangement might be better served by establishing a NEWCO. Regulatory Depending on configuration and location of the clinic, there may be a number of steps involved with transferring the clinic from one hospital license to another. Otherwise, there are no new regulatory requirements. Management/ Governance This model creates significant financial integration and allows both organizations to collaborate clinically without disrupting current services. A JOC would be established to govern the services covered within the JOA. Economic integration and shared governance facilitate enhanced clinical coordination of the program. 23
25 IV. Future of 340B and Potential Pitfalls Audit Report Findings 340B participants are subject to audit. A review of a recent HRSA audit report revealed a few common pitfalls, providing the following lessons learned: Eligibility Make certain the 340B medications are given to eligible patients only. Confirm prescriptions are written by an eligible provider. Record Keeping Keep accurate and up-to-date records, including the authorizing official and primary office location and contact information. Registration Notify the OPA of any changes, such as contracts with pharmacies and changes in outpatient facility operations (i.e., closures), through the registration process. Billing Perform appropriate billing (e.g., avoid duplicate discounts). Failure to comply may result in removal from the program or in refunds to drug manufacturers. 24
26 IV. Future of 340B and Potential Pitfalls The Outlook for 340B Interviews To gain a better understanding of the future outlook for 340B, ECG contacted two Washington, D.C., policy experts regarding conversations that are occurring at the federal level. Individual Position Background Ms. Melinda Hatton Ms. Jennifer Bell Senior Vice President and General Counsel, American Hospital Association (AHA) Co-Founder, Chamber Hill Strategies (Washington Lobbying Firm) Ms. Hatton provides leadership on all legal and advocacy matters for the AHA. She supervises all advocacy-related litigation, including administrative and class-action litigation. She also directly oversees the AHA s work on tax exemption, medical privacy, antitrust, fraud and abuse, and other related regulatory matters and congressional investigations. Prior to joining the AHA, Ms. Hatton was a partner at the law firm of Hogan & Hartson. She also served as antitrust counsel to the Senate Judiciary Committee s Antitrust Subcommittee. Ms. Bell lobbies for healthcare issues for a variety of public- and privatesector clients. Prior to her lobbying career, Ms. Bell served as a health policy advisor for Sen. Charles Grassley (R-IA) on the Senate Finance Committee, where she developed and managed legislative initiatives regarding Medicare fee-for-service programs, including passage and implementation of the Medicare Modernization Act of She also has extensive experience in working in the House of Representatives and the Senate Committee on Health, Education, Labor, and Pensions (HELP). 25
27 IV. Future of 340B and Potential Pitfalls Overall Outlook for 340B Based on our conversations, it appears that 340B remains a widely popular program among key stakeholders and most lawmakers. From a regulatory perspective, efforts are focused on improving transparency of the program, ensuring compliance, and potentially expanding the scope. Broad Support The program enjoys a broad constituency of supporters, including hospitals, medical groups, and advocates for the poor and elderly. The reelection of President Barack Obama and the strong Democratic showing in the Senate elections are seen as positive developments from the perspective of program advocates. Cuts Unlikely The discussions about Medicare/Medicaid reimbursement reductions are not likely to affect 340B, according to the experts we consulted, as the program generates savings entirely at the expense of pharmaceutical companies. Pharmaceutical Industry The only significant opposition to the program arises from the pharmaceutical industry. According to Ms. Bell, this industry does not currently enjoy high levels of support from leaders in Congress. Simplification The main critique of the program, according to the interviewees, is its complexity and organization. Likely future changes include streamlining and expansion. Slow to Change Further, our interviewees emphasized that the elimination of the program (if this were to occur) would likely require years of debate. Major changes to programs such as 340B usually require many years to take effect. 26
28 Matthew R. Sturm ECG Management Consultants, Inc
About Baptist Medical Center
About Baptist Medical Center Locally owned and operated in Jacksonville, Florida BMC includes 2 Adult and 1 Children s Hospital 960 licensed beds Disproportionate Share Hospital Recently opened Baptist
More information340B Compliance. Overview
340B Compliance LIFE AFTER A HRSA AUDIT AND IMPLEMENTING A CORRECTIVE ACTION PLAN HCCA Compliance Institute March 27, 2017 Presented by: Melissa Singleton Sarah Bowman, CHC Overview 340B Program Background
More information340B Program Overview
340B Program Overview OSHP 77 th Annual Meeting Friday, April 22, 2016 Kevin Williams PharmD Candidate 2016 University of Cincinnati James L. Winkle College of Pharmacy Katie McKinney, PharmD, MS, BCPS
More information340B Program Mgr Vice President, Finance SVP, Chief Audit, Ethics & Compliance Officer
340B Drug Purchasing Program Page 1 of 7 340B Drug Purchasing Program Policy & Procedure Number Policy Manual Ethics and Compliance Type Policy & Procedure Document Owner Effective Date Next Review Date
More information340B DRUG PRICING PROGRAM
340B DRUG PRICING PROGRAM Lindsey Imada, PharmD Candidate 2016 Midwestern University, Chicago College of Pharmacy Pro Pharma Pharmaceutical Consultants, Inc. Under the preceptorship of Dr. Craig Stern
More informationIntroduction to 340B Part 1 of 2 February 5, 2014
Introduction to 340B Part 1 of 2 February 5, 2014 Lisa Scholz, PharmD, MBA Chief Operating Officer/Chief Pharmacy Officer Safety Net Hospitals for Pharmaceutical Access 10 th Annual 340B Winter Conference
More information340B Drug Program Summary
Summary Congress created section 340B of the Public Health Service Act in 1992 to allow eligible health care providers known as Covered Entities to stretch scarce Federal resources, reaching more patients
More informationOverview of the Federal 340B Drug Pricing Program
Overview of the Federal 340B Drug Pricing Program Presented by: James A. Raley, CPA Senior Manager Health Care Services Arnett Carbis Toothman LLP 345 340B Program: Overview Provides discounts on outpatient
More informationFederal Regulatory Policy Report. NACHC Study: Benefits of the 340B Drug Pricing Program for Health Centers
Federal Regulatory Policy Report NACHC Study: Benefits of the 340B Drug Pricing Program for Health Centers May 2011 NACHC Study on the Benefits of the 340B Drug Pricing Program for Health Centers May 2011
More informationObjectives. 340B Implementation and Audit Preparation. Section 340B of the Public Health Services Act of Disclaimer. MFR Agreement with 340B
340B Implementation and Audit Preparation Mike Loftus, RPh Assistant Director of Pharmacy Mercy Hospital Springfield 340B Program Administrator for Mercy Health System The speaker has no conflict of interest
More informationDobson DaVanzo & Associates, LLC Vienna, VA
Analysis of Patient Characteristics among Medicare Recipients of Separately Billable Part B Drugs from 340B DSH Hospitals and Non-340B Hospitals and Physician Offices Dobson DaVanzo & Associates, LLC Vienna,
More informationProfessional Services Arrangements
Tuesday, May 13, 2014 10 11 a.m. Central time Professional Services Arrangements Randy Biernat, CPA, ABV Director BKD, LLP rbiernat@bkd.com To Receive CPE Credit Participate in entire webinar Answer polls
More informationTaking Into Account Entire Supply Chain. Biopharmaceutical Companies
340B 101 Taking Into Account Entire Supply Chain Biopharmaceutical Companies Providers Payers and PBMs 2 Medicine Spending is in Line with Other Health Care Services Percent Annual Growth Rate Health Care
More information340B DRUG PRICING PROGRAM: 2016 EXPECTED UPDATES
340B DRUG PRICING PROGRAM: 2016 EXPECTED UPDATES P R E S E N T E D B Y : T H U Y L E, U S C S C H O O L O F P H A R M A C Y, C A N D I D A T E O F 2 0 1 7 P R E C E P T O R : C R A I G S T E R N, P H A
More information340 Program Compliance 2018 MICHIGAN FAMILY PLANNING UPDATE
340 Program Compliance 2018 MICHIGAN FAMILY PLANNING UPDATE 1 The 4-1-1 on 340B ENACTMENT Passed as part of Veteran s Health Care Act of 1992 to provide discounts on outpatient drugs to certain provider
More informationEVALUATING 340B HOSPITAL SAVINGS AND THEIR USE IN SERVING LOW-INCOME AND RURAL PATIENTS
EVALUATING 340B HOSPITAL SAVINGS AND THEIR USE IN SERVING LOW-INCOME AND RURAL PATIENTS Results from 340B Health s 2017 Annual Survey Savings from participating in the 340B drug pricing program are critical
More informationCAHABA GOVERNMENT BENEFIT ADMINISTRATORS (GBA) PROVIDER-BASED ATTESTATION STATEMENT. Main Provider Medicare Provider Number:
Main Provider Information: Main Provider Medicare Provider Number: Main Provider Legal Business Name: Main Provider Doing Business As Name: Main Provider s Address: Attestation Contact Name (please print):
More informationHospital/Physician Affiliation Trends. December 6, 2011
Hospital/Physician Affiliation Trends December 6, 2011 Hospital Strategies in 2011 I. Introduction VMG Health ( VMG ) Jim Rolfe Biography Jen Johnson, CFA Biography II. Hospital Market III. Hospital Acquisitions
More informationWorking Paper Series
The Financial Benefits of Critical Access Hospital Conversion for FY 1999 and FY 2000 Converters Working Paper Series Jeffrey Stensland, Ph.D. Project HOPE (and currently MedPAC) Gestur Davidson, Ph.D.
More informationUpdate on 340B Drug Pricing Program
Update on 340B Drug Pricing Program LCDR Joshua E. Hardin MBA, RN/BSN, MLT Donna Murray Office of Pharmacy Affairs U.S. Department of Health and Human Services Health Resources and Services Administration
More informationSummary of U.S. Senate Finance Committee Health Reform Bill
Summary of U.S. Senate Finance Committee Health Reform Bill September 2009 The following is a summary of the major hospital and health system provisions included in the Finance Committee bill, the America
More informationSubtitle E New Options for States to Provide Long-Term Services and Supports
LONG TERM CARE (SECTION-BY-SECTION ANALYSIS) (Information compiled from the Democratic Policy Committee (DPC) Report on The Patient Protection and Affordable Care Act and the Health Care and Education
More informationAREAS OF RESPONSIBILITY
Applies To: UNMH and UNMCC Responsible Department: Pharmacy Revised: 5/1/2016 Guideline Patient Age Group: (x) N/A ( ) All Ages ( ) Newborns ( ) Pediatric ( ) Adult DESCRIPTION/OVERVIEW This document contains
More informationOverview of Select Health Provisions FY 2015 Administration Budget Proposal
Overview of Select Health Provisions FY 2015 Administration Budget Proposal On March 4, 2014, President Obama released his Administration s FY 2015 budget proposal to Congress. The budget contains a number
More informationpaymentbasics The IPPS payment rates are intended to cover the costs that reasonably efficient providers would incur in furnishing highquality
Hospital ACUTE inpatient services system basics Revised: October 2015 This document does not reflect proposed legislation or regulatory actions. 425 I Street, NW Suite 701 Washington, DC 20001 ph: 202-220-3700
More informationDESCRIPTION/OVERVIEW This document contains descriptions of the procedures used at UNM Hospital to maintain compliance with the 340B Program.
Applies To: UNMH, UNMCC Responsible Department: Pharmacy Revised: 10/2014 Guideline Patient Age Group: (X ) N/A ( ) All Ages ( ) Newborns ( ) Pediatric ( ) Adult DESCRIPTION/OVERVIEW This document contains
More informationAppendix B: Formulae Used for Calculation of Hospital Performance Measures
Appendix B: Formulae Used for Calculation of Hospital Performance Measures ADJUSTMENTS Adjustment Factor Case Mix Adjustment Wage Index Adjustment Gross Patient Revenue / Gross Inpatient Acute Care Revenue
More informationThe Patient Protection and Affordable Care Act Summary of Key Health Information Technology Provisions June 1, 2010
The Patient Protection and Affordable Care Act Summary of Key Health Information Technology Provisions June 1, 2010 This document is a summary of the key health information technology (IT) related provisions
More informationSubmitted electronically:
Mr. Andy Slavitt Acting Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Attention: CMS-5517-FC P.O. Box 8013 7500 Security Boulevard Baltimore, MD 21244-8013
More informationPhysician Compensation in an Era of New Reimbursement Models
2014 IHA Annual Membership Meeting Physician Compensation in an Era of New Reimbursement Models Taryn E. Stone Ice Miller LLP (317) 236-5872 taryn.stone@ Agenda Background New Reimbursement Models Trends
More informationPartnering with hospitals to create an accountable care organization Elias N. Matsakis, Esq.
Partnering with hospitals to create an accountable care organization Elias N. Matsakis, Esq. There are many opportunities for physicians and hospitals to affiliate and clinically integrate so as to enable
More informationPassage of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA): The Doc Fix
April, 2015 Passage of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA): The Doc Fix Author: Annemarie Wouters, Senior Advisor The President has signed into law the bipartisan bill H.R. 2,
More informationbeyond the pharmacy Common 340B program concerns for hospitals Making sure expectations meet reality March 13, 2015
beyond the pharmacy Common 340B program concerns for hospitals Making sure expectations meet reality March 13, 2015 Lidia A. Rodriguez-Hupp SVP & 340B Compliance Officer Christopher Boles Regional VP,
More informationMedicaid Update Special Edition Budget Highlights New York State Budget: Health Reform Highlights
Page 1 of 6 New York State April 2009 Volume 25, Number 4 Medicaid Update Special Edition 2009-10 Budget Highlights David A. Paterson, Governor State of New York Richard F. Daines, M.D. Commissioner New
More informationTRENDS IN CANCER PROGRAMS
A by the Association of Community Cancer Centers 2014 TRENDS IN CANCER PROGRAMS A joint project between ACCC and Lilly Oncology, this report highlights YEAR 5 SURVEY RESULTS. WHO Took ACCC s? One hundred
More informationExecutive Summary, November 2015
Medicare Physician Fee Schedule Final Rule for Calendar Year 2016 Makes Changes in Stark Law Regulatory Provisions and Contains Important Updates of Medicare Payment Policies Executive Summary, November
More informationHRSA Audit Findings and Implications for Patient Definition
HRSA Audit Findings and Implications for Patient Definition August 20, 2015 Speakers: Maureen Testoni Senior Vice President and General Counsel Jeff Davis Counsel, Legal and Policy Affairs 2015 340B Health
More informationAgenda Based on Medicare / CMS Guidelines
January 2017 Jean C. Russell, MS, RHIT jrussell@epochhealth.com 518-369-4986 Richard Cooley, BS, CCS, rcooley@epochhealth.com 518-430-1144 Matthew H. Lawney, MSPT, MBA, CHC mlawney@epochhealth.com 845-642-6462
More informationHealth Care. Important Changes for Physicians from the 2016 Medicare Physician Fee Schedule: Part I (Stark Changes) February 2016.
in the news Health Care February 2016 Important Changes for Physicians from the 2016 Medicare Physician Fee Schedule: Part I (Stark Changes) O n November 16, 2015 the Centers for Medicare and Medicaid
More informationCRS Report for Congress Received through the CRS Web
CRS Report for Congress Received through the CRS Web Order Code RS20386 Updated April 16, 2001 Medicare's Skilled Nursing Facility Benefit Summary Heidi G. Yacker Information Research Specialist Information
More informationThe Society for Radiation Oncology Administrators 28 th Annual Meeting. Physician/Hospital Arrangements During a Period of Uncertain Healthcare Reform
The Society for Radiation Oncology Administrators 28 th Annual Meeting Physician/Hospital Arrangements During a Period of Uncertain Healthcare Reform Miami, Florida October 4, 2011 3025 Boardwalk Drive,
More information340B Compliance in an Era of Increased Oversight
340B Compliance in an Era of Increased Oversight Bill von Oehsen President/General Counsel Maureen Assistant General Counsel Wednesday, January 25, 2012 1:00-2:30 PM (Eastern Time) Phone: (800) 895-0231
More informationAdministrators. Medical Directors. 61% The negative impact on our hospital-based program s. 44% We will need to consider the most appropriate or most
2016 This annual survey, which began in 2009, provides key insight into nationwide developments in the business of cancer care. To better capture information from its multidisciplinary membership, this
More informationTransitioning to a Value-Based Accountable Health System Preparing for the New Business Model. The New Accountable Care Business Model
Transitioning to a Value-Based Accountable Health System Preparing for the New Business Model Michael C. Tobin, D.O., M.B.A. Interim Chief medical Officer Health Networks February 12, 2011 2011 North Iowa
More information340B Savings Equal Improved Patient Care
340B Savings Equal Improved Patient Care Lisa Scholz, PharmD, MBA Chief Operating Officer/Chief Pharmacy Officer Safety Net Hospitals for Pharmaceutical Access 10 th Annual 340B Coalition Winter Conference
More informationTHE IMPACT OF 340B REIMBURSEMENT CUTS ON CANCER CENTERS
THE IMPACT OF 340B REIMBURSEMENT CUTS ON CANCER CENTERS PRESENTERS Jeff Davis Senior Advisor and Of Counsel Baker Donelson Cheryl L. Willman, MD Director and CEO UNM Comprehensive Cancer Center Sandra
More informationProvider Based Status Compliance: Space Sharing and Reimbursement Charges
Provider Based Status Compliance: Space Sharing and Reimbursement Charges Presentation by Karen Smith 614.227.2313 ksmith@bricker.com Claire Turcotte 513.870.6573 cturcotte@bricker.com Bricker & Eckler
More informationINFORMATION ABOUT YOUR OXFORD COVERAGE REIMBURSEMENT PART I OXFORD HEALTH PLANS OXFORD HEALTH PLANS (NJ), INC.
OXFORD HEALTH PLANS (NJ), INC. INFORMATION ABOUT YOUR OXFORD COVERAGE PART I REIMBURSEMENT Overview of Provider Reimbursement Methodologies Generally, Oxford pays Network Providers on a fee-for-service
More information10/12/2017 COST REPORTING 201. October 18, Michael K. Westerfield, CPA, FHFMA Senior Manager
COST REPORTING 201 October 18, 2017 Michael K. Westerfield, CPA, FHFMA Senior Manager 1 AGENDA Cost Report 101 Review Wage Index Disproportionate Share S-10 Indirect Medical Education (IME) Graduate Medical
More informationHospice Program Integrity Recommendations
Hospice Program Integrity Recommendations Projected increases in the elderly population and the number of Medicare beneficiaries will likely result in continued growth in utilization of hospice services.
More informationHealth Reform and IRFs
American Medical Rehabilitation Providers Association 8 th Annual AMRPA Educational Conference New Orleans, LA Health Reform and IRFs Planning Today for Success Tomorrow October 14, 2010 Agenda Introduce
More informationStrategic Plan Our Path to Providing Excellence in Health Care
Strategic Plan 2014-2016 Our Path to Providing Excellence in Health Care Dear Community Members, As your publicly elected commissioners of Clallam County Public Hospital District No. 2, we are dedicated
More informationReimbursement Models of the Future A Look at Proposed Models
Experience the Eide Bailly Difference Reimbursement Models of the Future A Look at Proposed Models Ralph J. Llewellyn, CPA, CHFP Partner rllewellyn@eidebailly.com 701.239.8594 Introduction CAH reimbursement
More informationWhy Should Providers Care about Provider-Based Billing and Reimbursement?
Why Should Providers Care about Provider-Based Billing and Reimbursement? Kim Harvey Looney kim.looney@wallerlaw.com Donna K. Gilley gilley.donna@cogenthealthcare.com 2013 Waller Lansden Dortch & Davis,
More informationSelf-Referral, Markups, Fee Splitting, and Related Practices
Policy Statement Self-Referral, Markups, Fee Splitting, and Related Practices (Policy Number 04-03) Policy Statement ASCP strongly supports federal and state self-referral prohibitions, anti-markup requirements
More informationProvider-Based Hospital Departments Are We Compliant?
Critical Access Hospital and Provider-Based Hospital Departments Are We Compliant? September 14, 2017 1 Reasons for Hospital/Clinic Integration History of Provider-Based Regulations Provider-Based Requirements
More informationSec. 1. Short Title Specifies the short title of the legislation as the SBIR/STTR Reauthorization Act of Title I Reauthorization of Programs
S. 2793, SBIR/STTR Reauthorization Act of 2016 Ranking Member Shaheen and Chairman Vitter U.S. Senate Committee on Small Business and Entrepreneurship Section-by-section Sec. 1. Short Title Specifies the
More informationDivision C: Increasing Choice, Access, and Quality in Health Care for Americans TITLE XV: Provisions Relating to Medicare Part A
Division C: Increasing Choice, Access, and Quality in Health Care for Americans TITLE XV: Provisions Relating to Medicare Part A Sec. 15001. Development of Medicare study for HCPCS versions of MS-DRG codes
More informationAnalysis of 340B Disproportionate Share Hospital Services to Low- Income Patients
Analysis of 340B Disproportionate Share Hospital Services to Low- Income Patients March 12, 2018 Prepared for: 340B Health Prepared by: L&M Policy Research, LLC 1743 Connecticut Ave NW, Suite 200 Washington,
More informationTexas Health Care Transformation and Quality Improvement Program - FAQ
Texas Health Care Transformation and Quality Improvement Program - FAQ http://www.hhsc.state.tx.us/1115-faq.shtml 1115 Waiver Approval and Effective Date Why is HHSC seeking an 1115 waiver under the Social
More informationJoint Statement on Ambulance Reform
Joint Statement on Ambulance Reform Policymakers Should Examine Short- and Intermediate-Term Policies to Promote Innovation in the Delivery of Emergency and Non- Emergency Care Provided by Ambulance Services
More informationEstimated Decrease in Expenditure by Service Category
Public Notice for June 2009 Release PUBLIC NOTICE COLORADO MEDICAID Department of Health Care Policy and Financing Fee-for-Service Provider Payments Effective July 1, 2009, in an effort to reduce expenditures
More informationProvider-Based Status, Under Arrangements, and Related Medicare Requirements
Provider-Based Status, Under Arrangements, and Related Medicare Requirements AHLA Medicare & Medicaid Law Institute Baltimore, MD March 26, 2015 Andrew Ruskin Lawrence Vernaglia Morgan Lewis & Bockius
More informationGENERAL ASSEMBLY OF NORTH CAROLINA SESSION SENATE DRS15110-MGx-29G (01/14) Short Title: HealthCare Cost Reduction & Transparency.
S GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 01 SENATE DRS-MGx-G (01/1) FILED SENATE Mar, 01 S.B. PRINCIPAL CLERK D Short Title: HealthCare Cost Reduction & Transparency. (Public) Sponsors: Referred to:
More informationThe influx of newly insured Californians through
January 2016 Managing Cost of Care: Lessons from Successful Organizations Issue Brief The influx of newly insured Californians through the public exchange and Medicaid expansion has renewed efforts by
More informationProfiles in CSP Insourcing: Tufts Medical Center
Profiles in CSP Insourcing: Tufts Medical Center Melissa A. Ortega, Pharm.D., M.S. Director, Pediatrics and Inpatient Pharmacy Operations Tufts Medical Center Hospital Profile Tufts Medical Center (TMC)
More informationAMERICAN HEALTH LAWYERS ASSOCIATION Institute on Medicare and Medicaid Payment Issues. March 20-22, 2013 Baltimore, MD
AMERICAN HEALTH LAWYERS ASSOCIATION Institute on Medicare and Medicaid Payment Issues Provider-Based Status, Under Arrangements, and Related Medicare Principles and Requirements March 20-22, 2013 Baltimore,
More informationThe Patient Protection and Affordable Care Act (Public Law )
Policy Brief No. 2 March 2010 A Summary of the Patient Protection and Affordable Care Act (P.L. 111-148) and Modifications by the On March 23, 2010, President Obama signed into law the Patient Protection
More informationFurthering the agency s stated intention to pay for value over volume,
in the news Health Care September 2016 The Future Is Now: CMS Proposes Broad Bundled Payment Expansion for Cardiac Care Episodes In this Issue: Episode Payment Models... 2 Cardiac Rehabilitation Incentives...
More informationMedicare: "Complex regulatory structure."
IHA Legal Forum for Hospital Executives and Counsel Medicare Reimbursement Update September 16, 2016 Regan E. Tankersley Medicare: "Complex regulatory structure." 2 1 Objectives Medicare Provider Based
More informationLegal Issues You Should Know April 25, 2018 In-House Counsel Conference
1 TELEMEDICINE Legal Issues You Should Know April 25, 2018 In-House Counsel Conference Disclaimer: These materials and presentation are intended to be a general and brief summary of the law. This is not
More informationJeremiah McWilliams, PharmD
Jessica Blackburn Vice President, 340B Advisors, LLC Attorney, Pointer Law Office, P.C. Jeremiah McWilliams, PharmD Senior Director, 340B Account Services Wellpartner, Inc HRSA Audits began 2012 Total
More informationGraduate Medical Education Payments. Mark Miller, PhD Executive Director February 20, 2015
Graduate Medical Education Payments Mark Miller, PhD Executive Director February 20, 2015 About MedPAC Independent, nonpartisan Congressional support agency 17 national experts selected for expertise Appointed
More informationHospital Outpatient 1206(d) Clinics Legal Considerations Impacting Physicians
Document #5401 Hospital Outpatient 1206(d) Clinics Legal Considerations Impacting Physicians CMA Legal Counsel, January 2015 California hospitals are increasingly operating outpatient clinics as a vehicle
More informationComparison of ACP Policy and IOM Report Graduate Medical Education That Meets the Nation's Health Needs
IOM Recommendation Recommendation 1: Maintain Medicare graduate medical education (GME) support at the current aggregate amount (i.e., the total of indirect medical education and direct graduate medical
More informationComparison of the Health Provisions in HR 1 American Recovery and Reinvestment Act
APPROPRIATIONS Comparative Effectiveness Research $1.1B for comparative effectiveness programs, including $300 M for AHRQ, $400 M for NIH, and $400 M for HHS. Establishes a Federal Coordinating Council.
More informationCenters for Medicare & Medicaid Services: Innovation Center New Direction
Centers for Medicare & Medicaid Services: Innovation Center New Direction I. Background One of the most important goals at CMS is fostering an affordable, accessible healthcare system that puts patients
More informationOMC Strategic Plan Final Draft. Dear Community, Working together to provide excellence in health care.
Dear Community, Working together to provide excellence in health care. This mission statement, established nearly two decades ago, continues to be fulfilled by our employees and medical staff. This mission
More informationIndiana Hospital Assessment Fee -- DRAFT
Indiana Hospital Assessment Fee -- DRAFT September 27, 2011 Inpatient Fee The initial Indiana Inpatient Hospital Fee applies to inpatient days from each hospital's most recent FYE as taken from the cost
More informationIntegrated Leadership for Hospitals and Health Systems: Principles for Success
Integrated Leadership for Hospitals and Health Systems: Principles for Success In the current healthcare environment, there are many forces, both internal and external, that require some physicians and
More informationAmerican Health Lawyers Association Institute on Medicare and Medicaid Payment Issues. History of the Physician Fee Schedule
American Health Lawyers Association Institute on Medicare and Medicaid Payment Issues March 20-22, 2013 Baltimore, Maryland Sidney S. Welch, Esq. 1 History of the Physician Fee Schedule Prior to 1992,
More informationACOs the Medicare Shared Savings Program And Other Healthcare Reform Payment Methods
A unique vision for an ever-changing healthcare environment ACOs the Medicare Shared Savings Program And Other Healthcare Reform Payment Methods Presented by Joe Laden, President, ORVA, LLC The Environment
More informationCOOK COUNTY HEALTH & HOSPITALS SYSTEM
COOK COUNTY HEALTH & HOSPITALS SYSTEM Strategic Planning Town Hall Meetings May 2016 Strategic Planning Timeline February-June 2016 Strategic planning presentations and discussions at CCHHS Board of Directors
More informationMeaningful Use of EHR Technology:
Meaningful Use of EHR Technology: What Do the New Standards and Certification Criteria Mean for Your Organization? January 20, 2010 Mitchell J. Olejko Ropes & Gray LLP mitchell.olejko@ropesgray.com 415-315-6328
More informationGuidelines for the Major Eligible Employer Grant Program
Guidelines for the Major Eligible Employer Grant Program Purpose: The Major Eligible Employer Grant Program ( MEE ) is used to encourage major basic employers to invest in Virginia and to provide a significant
More informationMedicare Provider-Based Designation Attestation
Medicare Provider-Based Designation Attestation TO: All Main Providers In order for a facility to be designated as provider-based for billing and payment purposes, it must meet the applicable requirements
More informationPHYSICIAN COMPENSATION MODELS IN A CHANGING ENVIRONMENT
PHYSICIAN COMPENSATION MODELS IN A CHANGING ENVIRONMENT Ralph Llewellyn, CPA, CHFP Partner rllewellyn@eidebailly.com 701-239-8594 Michele Olivier, CPC, CPMA, Consultant molivier@eidebailly.com 303-586-8529
More informationExecutive, Legislative & Regulatory 2018 AGENDA. unitypoint.org/govaffairs
Executive, Legislative & Regulatory 2018 AGENDA unitypoint.org/govaffairs Dear Policy Makers and Community Stakeholders, In the midst of tumultuous times, we bring you our 2018 State Legislative Agenda.
More informationCROSS-COMMUNITY SUMMIT SESSION 2 CONSIDERATIONS FOR HEALTH CENTERS AND HOSPITALS IN DEVELOPING SUCCESSFUL PARTNERSHIPS. Speakers:
SESSION 2 CONSIDERATIONS FOR HEALTH CENTERS AND HOSPITALS IN DEVELOPING SUCCESSFUL PARTNERSHIPS Speakers: Arthur Jones, M.D., Principal, has over 25 years of experience as a founding physician and CEO
More informationCurrent Trends in the 340B Drug Pricing Program. November 8, 2011
Current Trends in the 340B Drug Pricing Program November 8, 2011 Housekeeping Welcome to our webinar on the HRSA s 340B Program Below are some webinar housekeeping items: Kick-off polling question. Please
More informationRationale for Acquisition of St. Paul and Zale Lipshy University Hospitals. History of the UTSW- University Hospital Relationship
Rationale for Acquisition of St. Paul and Zale Lipshy University Hospitals UT Southwestern Medical Center Presentation to Regents May 12, 2004 History of the UTSW- University Hospital Relationship Growth
More informationExecutive Summary BERKELEY RESEARCH GROUP COMPLIANCE TRENDS WITH HOSPITAL CHARITY CARE REQUIREMENTS
Executive Summary Study Background: The Affordable Care Act (ACA) established new requirements for 501(c)(3) hospitals pertaining to their charity care policies. Hospitals self-report data related to these
More informationCourse Module Objectives
Course Module Objectives CM100-18: Scope of Services, Practice, and Education CM200-18: The Professional Case Manager Case Management History, Regulations and Practice Settings Case Management Scope of
More informationMEDICARE FFY 2017 PPS PROPOSED RULES OVERVIEW OHA Finance/PFS Webinar Series. May 10, 2016
MEDICARE FFY 2017 PPS PROPOSED RULES OVERVIEW 2016 OHA Finance/PFS Webinar Series May 10, 2016 Spring is Medicare PPS Proposed Rules Season Inpatient Hospital Long-Term Acute Care Hospital Inpatient Rehabilitation
More informationCOMPLIANCE MONITORING CHECKLIST
HOSPITAL COMPLIANCE MONITORING CHECKLIST Return To: Year Ending: December 31, 2005 Email: Affiliate: Person Completing: Fax: All "No" answers should include an explanation in the General Comments column.
More informationThe Influence of Health Policy on Clinical Practice. Dr. Kim Kuebler, DNP, APRN, ANP-BC Multiple Chronic Conditions Resource Center
The Influence of Health Policy on Clinical Practice Dr. Kim Kuebler, DNP, APRN, ANP-BC Multiple Chronic Conditions Resource Center Disclaimer Director: Multiple Chronic Conditions Resource Center www.multiplechronicconditions.org
More informationHealth Care Reform and Challenges for CMS
Health Care Reform and Challenges for CMS Transparent Pricing Benchmarks Conference May 26, 2010 Thomas Barker tbarker@foleyhoag.com 2010 Foley Hoag LLP. All Rights Reserved. Presentation Title Agenda
More informationCaution: DRAFT NOT FOR FILING
Caution: DRAFT NOT FOR FILING This is an early release draft of an IRS tax form, instructions, or publication, which the IRS is providing for your information as a courtesy. Do not file draft forms. Also,
More informationPHYSICIAN ARRANGEMENT INTEGRITY: BALANCING PROCESS AND EXPENSE BECKER S 5 TH ANNUAL CEO + CFO ROUNDTABLE NOVEMBER 7-9, 2016
PHYSICIAN ARRANGEMENT INTEGRITY: BALANCING PROCESS AND EXPENSE 1 BECKER S 5 TH ANNUAL CEO + CFO ROUNDTABLE NOVEMBER 7-9, 2016 Jennifer Johnson,CFA Managing Director VMG Health Jen.johnson@vmghealth.com
More informationpaymentbasics Defining the inpatient acute care products Medicare buys Under the IPPS, Medicare sets perdischarge
Hospital ACUTE inpatient services system basics Revised: October 2007 This document does not reflect proposed legislation or regulatory actions. 601 New Jersey Ave., NW Suite 9000 Washington, DC 20001
More information